Possibilities of using gluco-corticosteroids in the outpatient treatment of patients with COVID-19
- Autores: Kiselev Y.Y.1, Mirzaev K.B2
-
Afiliações:
- OsloMet- Oslo Metropolitan University
- Russian Medical Academy of Continuing Professional Education
- Edição: Volume 27, Nº 13 (2020)
- Páginas: 12-13
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/312957
- DOI: https://doi.org/10.18565/pharmateca.2020.13.12-13
- ID: 312957
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
As compared to the treatment of patients with severe and extremely severe coronavirus infection (COVID-19), the use of glucocorticosteroids (GCS) for mild cases is not indicated. In line with the recommendations of the Ministry of Health of the Russian Federation, GCS therapy at the outpatient stage is allowed only for patients who meet the criteria for a moderate course, taking into account a number of restrictions and with a thorough assessment of the risk of side effects. Foreign recommendations declare rather against the routine use of GCS outside of situations of severe and extremely severe course.
Palavras-chave
Texto integral
Sobre autores
Yu. Kiselev
OsloMet- Oslo Metropolitan UniversityDepartment of Life Sciences and Health
K. Mirzaev
Russian Medical Academy of Continuing Professional Education
Bibliografia
- Group R.C., Horby P, Lim W.S., et al. Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. N Engl J Med. 2020. doi: 10.1056/NEJMoa2021436
- Временные методические рекомендации МЗ РФ, 26.10.2020. URL: https://static-0.minzdrav.gov. ru/system/attachments/attaches/000/052/550/ original/%D0%9C%D0%A0_CQVID-19_%28v9%29.pdf?1603788097 (Accessed 18.11.2020)
- A living WHO guideline on drugs for covid-19. URL: https://doi.org/10.1136/bmj.m3379 (Accessed 18.11.2020)
- National COVID-19 Clinical Evidence Taskforce. URL: https://covid19evidence.net.au (Accessed 18.11.2020)
- NIH COVID-19 treatment guidelines. URL: https://files.covid19treatmentguidelines.nih. gov/guidelines/covid19treatmentguidelines.pdf (Accessed 18.11.2020)
- NICE Corticosteroids prescribing briefing. URL: https://www.nice.org.uk/gkidance/ng15g/ resources/covid19-prescribing-briefing-corticosteroids-pdf-8839913581 (Accessed 18.11.2020)
- Narum S, Westergren T, Klemp M. Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis. BMJ Open. 2014;4(5):e004587. Doi: 10.1136/ bmjopen-pO 1.2-004007
Arquivos suplementares
